| Primary |
| Hypercholesterolaemia |
34.4% |
| Hyperlipidaemia |
15.8% |
| Blood Cholesterol Increased |
14.8% |
| Dyslipidaemia |
8.8% |
| Hypertension |
4.3% |
| Diabetes Mellitus |
3.1% |
| Blood Cholesterol |
2.9% |
| Type 2 Diabetes Mellitus |
2.4% |
| Acute Myocardial Infarction |
2.1% |
| Constipation |
1.9% |
| Low Density Lipoprotein Increased |
1.7% |
| Blood Cholesterol Abnormal |
1.2% |
| Coronary Artery Disease |
1.2% |
| Myocardial Infarction |
1.0% |
| Peripheral Arterial Occlusive Disease |
1.0% |
| Type Iia Hyperlipidaemia |
1.0% |
| Cardiac Disorder |
0.7% |
| Cardiac Failure Chronic |
0.7% |
| High Cholesterol |
0.7% |
| Asthma |
0.5% |
|
| Rhabdomyolysis |
27.3% |
| Myalgia |
8.5% |
| Blood Creatine Phosphokinase Increased |
7.3% |
| Aspartate Aminotransferase Increased |
4.8% |
| Pyrexia |
4.8% |
| Myocardial Infarction |
4.2% |
| Nasopharyngitis |
4.2% |
| Vomiting |
4.2% |
| Alanine Aminotransferase Increased |
3.6% |
| Chest Pain |
3.6% |
| Hepatic Function Abnormal |
3.6% |
| Liver Disorder |
3.0% |
| Muscle Spasms |
3.0% |
| Muscular Weakness |
3.0% |
| Pain In Extremity |
3.0% |
| Tremor |
3.0% |
| Convulsion |
2.4% |
| Rash |
2.4% |
| Chest Discomfort |
1.8% |
| Condition Aggravated |
1.8% |
|
| Secondary |
| Hypertension |
24.4% |
| Hypercholesterolaemia |
11.6% |
| Hyperlipidaemia |
11.2% |
| Diabetes Mellitus |
7.2% |
| Product Used For Unknown Indication |
6.6% |
| Rheumatoid Arthritis |
5.4% |
| Dyslipidaemia |
4.2% |
| Constipation |
3.6% |
| Anxiety |
3.2% |
| Hyperuricaemia |
2.6% |
| Schizophrenia |
2.6% |
| Angina Unstable |
2.4% |
| Blood Cholesterol Increased |
2.4% |
| Drug Use For Unknown Indication |
2.4% |
| Gastric Ulcer |
2.0% |
| Insomnia |
1.8% |
| Myocardial Infarction |
1.8% |
| Bronchitis Chronic |
1.6% |
| Osteoporosis Prophylaxis |
1.6% |
| Rhinitis Allergic |
1.6% |
|
| Liver Disorder |
16.0% |
| Rhabdomyolysis |
8.4% |
| Thrombocytopenic Purpura |
8.4% |
| Hepatic Function Abnormal |
7.6% |
| Lymphocyte Stimulation Test Positive |
6.7% |
| Drug Hypersensitivity |
5.0% |
| Interstitial Lung Disease |
5.0% |
| Neuroleptic Malignant Syndrome |
5.0% |
| Cerebral Infarction |
4.2% |
| Pneumonia |
4.2% |
| Vomiting |
4.2% |
| White Blood Cell Count Decreased |
4.2% |
| Muscle Spasms |
3.4% |
| Nausea |
3.4% |
| Agranulocytosis |
2.5% |
| Drug-induced Liver Injury |
2.5% |
| Pemphigus |
2.5% |
| Renal Impairment |
2.5% |
| Sepsis |
2.5% |
| Aspartate Aminotransferase Increased |
1.7% |
|
| Concomitant |
| Hypertension |
15.8% |
| Product Used For Unknown Indication |
11.8% |
| Hepatitis C |
10.9% |
| Hyperlipidaemia |
10.6% |
| Rheumatoid Arthritis |
7.1% |
| Prophylaxis |
6.3% |
| Chronic Hepatitis C |
5.8% |
| Diabetes Mellitus |
5.1% |
| Iron Deficiency Anaemia |
3.2% |
| Constipation |
3.0% |
| Type 2 Diabetes Mellitus |
2.9% |
| Insomnia |
2.7% |
| Gastritis |
2.6% |
| Angina Pectoris |
2.4% |
| Atrial Fibrillation |
2.1% |
| Osteoporosis |
1.8% |
| Hypercholesterolaemia |
1.7% |
| Dyslipidaemia |
1.5% |
| Gastric Ulcer |
1.4% |
| Myocardial Infarction |
1.4% |
|
| Anaemia |
22.5% |
| Rash |
15.5% |
| Renal Disorder |
10.2% |
| Platelet Count Decreased |
5.3% |
| Interstitial Lung Disease |
4.4% |
| Vomiting |
3.8% |
| Renal Impairment |
3.6% |
| Hepatic Function Abnormal |
3.5% |
| Hypoglycaemia |
3.3% |
| Pyrexia |
3.3% |
| Myocardial Infarction |
2.9% |
| Cardiac Failure |
2.7% |
| Nausea |
2.5% |
| Urinary Tract Infection |
2.5% |
| Decreased Appetite |
2.4% |
| Flushing |
2.4% |
| Pneumonia |
2.4% |
| Renal Failure Acute |
2.4% |
| White Blood Cell Count Increased |
2.4% |
| Cerebral Infarction |
2.2% |
|
